4
Changes in Ownership
GALECTIN THERAPEUTICS INC Filed Acc 0001133416-26-000002
Chief Medical Officer sold 8,125 shares at $4.07 ($33,089)
- Chief Medical Officer acquired 8,125 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jamil Khurram · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-31 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,125 | $1.23 | $9,994 | 8,125 | D |
| 2025-12-31 | Sale : show line 2 in the form 10b5-1 | −8,125 | $4.07 | $33,089 | 0 | D |
| Open-market sales · 8,125 sh · avg $4.07 · $33,089 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-31 | Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) | −8,125 | 40,625 | D |
Loading xslF345X05/form4.xml…